SCHEMBL20123934

SCHEMBL20123934

CC/C(C)=C(C)/C=C\c1c(C)ccn2nc(CCc3ccc4ncccc4n3)nc12

nearest known ligand 0.46

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 20/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21323885 0.78 PDE10A (0.57) PDE10A
SCHEMBL20123909 0.74 PDE10A (0.46) PDE10A
SCHEMBL12066287 0.74 PDE10A (0.75) PDE10A
SCHEMBL15023597 0.73 PDE10A (0.61) PDE10A
SCHEMBL15033438 0.72 PDE10A (0.65) PDE10A
SCHEMBL20123992 0.69 PDE10A (0.38) PDE10A
SCHEMBL12068902 0.67 PDE10A (0.46) PDE10A
SCHEMBL12068236 0.67 PDE10A (0.74) PDE10A
SCHEMBL12066639 0.66 PDE10A (0.65) PDE10A
SCHEMBL7520568 0.66 PDE10A (0.79) PDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3318561-B1 HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF SUNOVION PHARMACEUTICALS INC (US) 2021-12-22 EP disclosed
EP-2576540-B1 HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF SUNOVION PHARMACEUTICALS INC (US) 2019-09-04 EP disclosed
EP-3318561-A1 HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF Sunovion Pharmaceuticals Inc. (US) 2018-05-09 EP disclosed